Clinical Study
Implication of DNA Methylation Profiling in Oral Epithelium for
Lung Cancer Screening
Table 2
Frequency of promoter methylation in oral epithelium from lung cancer patients and controls.
|
Gene | Number (%) | ā | Symbol | Description | Patients () | Controls () | |
| APC | Adenomatous polyposis coli | 0 (0) | 0 (0) | N/A | GDNF | Glial cell line-derived neurotrophic factor | 7 (43.8) | 2 (6.3) | 0.0017 | RARB | Retinoic acid receptor beta | 6 (37.5) | 2 (6.3) | 0.0062 | GSTP1 | Glutathione S-transferase P 1 | 0 (0) | 0 (0) | N/A | TIMP3 | Tissue inhibitor of metalloproteinase-3 | 0 (0) | 0 (0) | N/A | MGMT | O6-methylguanine-DNA methyltransferase | 0 (0) | 0 (0) | N/A | RASSF1A | Ras association domain family 1 | 0 (0) | 0 (0) | N/A | MASPIN | Serpin peptidase inhibitor | 16 (100) | 32 (100) | N/A | CDH1 | Cadherin 1 | 0 (0) | 0 (0) | N/A | HS3ST2 | Heparan sulfate 3-O-sulfotransferase 2 | 4 (25.0) | 1 (3.1) | 0.0193 | CHARM1 | Cholinergic receptor, muscarinic 1 | 15 (93.8) | 28 (87.5) | n. s. |
|
|